Konu "Non-alcoholic fatty liver disease" için listeleme
Toplam kayıt 7, listelenen: 1-7
-
Evaluation of blink reflex in patients with steatosis
(Cukurova Univ, Fac Medicine, 2015)Purpose: the blink reflex (BR) is a useful electrodiagnostic method for evaluating neuropathies. the aim of our study was to investigate the role of the BR in the early diagnosis of neuropathy in simple steatosis. Material ... -
FIB-4 liver fibrosis index correlates with aortic valve sclerosis in non-alcoholic population
(Wiley, 2024)Aim: Hepatic fibrosis, a progressive scarring of liver tissue, is commonly caused by non-alcoholic fatty liver disease (NAFLD), which increases the risk of cardiovascular disease. The Fibrosis-4 (FIB-4) index is a non-invasive ... -
Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study
(Lippincott Williams & Wilkins, 2023)Background:Liver biopsy for the diagnosis of non-alcoholic steatohepatitis (NASH) is limited by its inherent invasiveness and possible sampling errors. Some studies have shown that cytokeratin-18 (CK-18) concentrations may ... -
The independent association of non-alcoholic fatty liver disease with lower urinary tract symptoms/benign prostatic hyperplasia and erectile function scores
(Wiley, 2019)Objectives To evaluate the association between non-alcoholic fatty liver disease (NAFLD) and lower urinary tract symptoms (LUTS)/benign prostate hyperplasia (BPH) and erectile function. Patients and methods in all, 356 men ... -
Interleukins: Pathogenesis in non-alcoholic fatty liver disease
(MDPI, 2024)Inflammatory cytokines have been implicated as crucial contributors to the onset and progression of non-alcoholic fatty liver disease (NAFLD). The exact mechanisms by which interleukins (ILs) contribute to NAFLD may vary, ... -
An international multidisciplinary consensus statement on MAFLD and the risk of CVD
(Springer, 2023)Background Fatty liver disease in the absence of excessive alcohol consumption is an increasingly common condition with a global prevalence of similar to 25-30% and is also associated with cardiovascular disease (CVD). ... -
Predicting fibrosis progression in non-alcoholic fatty liver disease patients using the FAST Score: A paired biopsy study
(Kare Publishing, 2024)Background and Aim: This study aimed to investigate the predictive value of various non-invasive scores for identifying the progression of hepatic fibrosis over time in patients with Non-Alcoholic Fatty Liver Disease ...